Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
40.8M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
9.31M
-
Shares change
-
+556K
-
Total reported value, excl. options
-
$131M
-
Value change
-
+$7.95M
-
Number of buys
-
34
-
Number of sells
-
-13
-
Price
-
$14.08
Significant Holders of RxSight, Inc. - Common Stock, par value $0.001 per share (RXST) as of Q2 2022
54 filings reported holding RXST - RxSight, Inc. - Common Stock, par value $0.001 per share as of Q2 2022.
RxSight, Inc. - Common Stock, par value $0.001 per share (RXST) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.31M shares
of 40.8M outstanding shares and own 22.82% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (3.05M shares), ORBIMED ADVISORS LLC (1.38M shares), BlackRock Inc. (943K shares), VANGUARD GROUP INC (672K shares), MILLENNIUM MANAGEMENT LLC (509K shares), BRIDGER MANAGEMENT, LLC (331K shares), Cresset Asset Management, LLC (316K shares), STATE STREET CORP (287K shares), GEODE CAPITAL MANAGEMENT, LLC (228K shares), and EAM Investors, LLC (176K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.